Monday , October 19 2026

FMCG Giants Under Fire: FSSAI Issues Show-Cause Notices To Nestlé And HUL Over Misleading Health Claims

In a major crackdown on corporate food packaging and promotional transparency across India, the Food Safety and Standards Authority of India (FSSAI) has served show-cause notices to consumer goods heavyweights Nestlé India and Hindustan Unilever Limited (HUL). The apex statutory food regulator acted following exhaustive examinations of public complaints, product labels, marketing claims, and e-commerce listings, identifying critical regulatory lapses and unsubstantiated functional health assertions on flagship nutritional supplements. The regulatory intervention signals a decisive tightening of compliance standards for fast-moving consumer goods (FMCG) operating within India’s booming retail and digital commerce ecosystems.

Unpacking The Violations: HUL’s Horlicks Mother’s Plus Under Regulator Lens

The regulatory notice directed at Hindustan Unilever focuses on its popular health drink formulation, Horlicks Mother’s Plus Kesar (400g BIB), as well as related nutrition drink variants. The food safety watchdog flagged marketing assertions that linked the beverage to guaranteed healthy birth weight outcomes during pregnancy, noting that such claims risk violating the Food Safety and Standards (Advertising and Claims) Regulations, 2018, by falsely implying that an isolated drink alone secures specific gestational metrics. In addition, the regulator reprimanded HUL for incorporating non-compliant functional assertions—such as “For Pregnancy and Lactation with Protein for Birth Weight and DHA for Brain Development – No Added Sugar”—directly into e-commerce product titles on digital marketplaces, which skirts statutory display norms and skews consumer decision-making.

Regulatory Lapses At Nestlé: Resource Renal Powder Flagged For Missing Authorisation

Concurrently, Nestlé India has been served a comprehensive notice concerning its specialized dietary supplement, Resource Renal vanilla-flavoured powder, which is marketed for patients managing chronic kidney disease (CKD) under conservative care. FSSAI established that Nestlé India failed to secure mandatory prior authorization before commercial release, breaching the rigorous framework of the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022. The authorities further discovered serious packaging deficiencies, including the absence of mandatory green or brown vegetarian and non-vegetarian declarations, representing a direct breach of the Food Safety and Standards (Labelling and Display) Regulations, 2020. Inconsistencies involving product classification and online descriptions for select ready-to-drink coffee lines were also placed under inquiry.

What Happens Next: Strict Deadlines And Broader Industry Implications

Both multinational food giants have been ordered to furnish comprehensive written explanations within the stipulated response period detailing their justification for the disputed claims and labelling omissions. The regulator highlighted that failure to provide adequate scientific and legal backing will trigger punitive measures under the Food Safety and Standards Act, which may include compounding fines, product recalls, or modifications of digital storefront listings. This aggressive oversight push underscores a nationwide mandate to curb deceptive dietary advertisements, shield vulnerable consumers—ranging from expectant mothers to renal patients—from exaggerated commercial claims, and force FMCG brands to strictly align their marketing rhetoric with scientifically verified product truths.